Patents by Inventor Earl W. Davie

Earl W. Davie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6025161
    Abstract: DNA sequences to mammalian .alpha..sub.1 -antitrypsin are provided which can be used for expression of mammalian .alpha..sub.1 -antitrypsin.This work was supported in part by grants HL16919 and HL27509 from the National Institutes of Health.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: February 15, 2000
    Assignee: Washington Research Foundation
    Inventors: Earl W. Davie, Kotoku Kurachi, Savio L. C. Woo, Chandra Thirumalachary
  • Patent number: 5736379
    Abstract: DNA sequences to mammalian .alpha..sub.1 -antitrypsin are provided which can be used for expression of mammalian .alpha..sub.1 -antitrypsin.This work was supported in part by grants HL16919 and HL27509 from the National Institutes of Health.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 7, 1998
    Assignee: Washington Research Foundation
    Inventors: Earl W. Davie, Kotoku Kurachi, Savio L. C. Woo, Chandra Thirumalachary
  • Patent number: 5399684
    Abstract: DNA sequences to mammalian .alpha..sub.1 -antitrypsin are provided which can be used for expression of mammalian .alpha..sub.1 -antitrypsin.
    Type: Grant
    Filed: July 2, 1993
    Date of Patent: March 21, 1995
    Assignee: Washington Research Foundation
    Inventors: Earl W. Davie, Kotoku Kurachi, Savio L. C. Woo, Chandra Thirumalachary
  • Patent number: 5302529
    Abstract: Genomic and cDNA sequences coding for a protein having substantially the same biological activity as human protein C are disclosed. Recombinant plasmids and bacteriophage transfer vectors incorporating these sequences are also disclosed.
    Type: Grant
    Filed: April 23, 1990
    Date of Patent: April 12, 1994
    Assignee: The Board of Regents of the University of Washington
    Inventors: Donald C. Foster, Earl W. Davie
  • Patent number: 5073609
    Abstract: Genomic and cDNA sequences coding for a protein having substantially the same biological activity as human protein C are disclosed. Recombinant plasmids and bacteriophage transfer vectors incorporating these sequences are also disclosed.
    Type: Grant
    Filed: June 29, 1989
    Date of Patent: December 17, 1991
    Assignee: The Board of Regents of the University of Washington
    Inventors: Donald C. Foster, Earl W. Davie
  • Patent number: 4994371
    Abstract: There is disclosed an isolated DNA sequence and the amino acid sequence for human factor IX. The isolated DNA sequence and its flanking sequences are useful for determining mutations, deletions or other modifications in genetic sequences expressing normal factor IX or modifications thereof.
    Type: Grant
    Filed: May 19, 1989
    Date of Patent: February 19, 1991
    Inventors: Earl W. Davie, Kotoku Kurachi
  • Patent number: 4968626
    Abstract: Genomic and cDNA sequences coding for a protein having substantially the same biological activity as human protein C are disclosed. Recombinant plasmids and bacteriophage transfer vectors incorporating these sequences are also disclosed.
    Type: Grant
    Filed: August 15, 1985
    Date of Patent: November 6, 1990
    Assignee: Board of Reagents of the University of Washington
    Inventors: Donald C. Foster, Earl W. Davie
  • Patent number: RE38981
    Abstract: Genomic and cDNA sequences coding for a protein having substantially the same biological activity as human protein C are disclosed. Recombinant plasmids and bacteriophage transfer vectors incorporating these sequences are also disclosed.
    Type: Grant
    Filed: August 13, 2002
    Date of Patent: February 14, 2006
    Assignee: Board of Regents of the University of Washington
    Inventors: Donald C. Foster, Earl W. Davie
  • Patent number: RE37958
    Abstract: Genomic and cDNA sequences coding for a protein having substantially the same biological activity as human protein C are disclosed. Recombinant plasmids and bacteriophage transfer vectors incorporating these sequences are also disclosed.
    Type: Grant
    Filed: June 15, 2001
    Date of Patent: January 7, 2003
    Assignee: Board of Regents of the University of Washington
    Inventors: Donald C. Foster, Earl W. Davie